Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (25854)	9/29/1998 4:33:00 PM
From: bluejeans	Read Replies (1) \| Respond to of 32384

Celery, The Notes will be redeemable by Ligand on or after the third anniversary of close, in cash at a price equal to the sum of the issue price plus accrued interest, subject to Elan's right to convert the Notes upon receipt of any redemption notice. Elan has the option to require Ligand to redeem the outstanding Notes on the fourth and seventh anniversary of close or in the event of a change of control of Ligand for a price calculated in the same manner. Elan has agreed to hold shares it acquires for two years from the closing and to a standstill at 25% subject to certain conditions. Elan will be granted registration rights under Ligand's current registration rights agreement. Possibly Ligand will use cash to pay off the note. If Elan requests to have the note converted to stock instead ; it appears that will start a 2 year holding period on the stock. Is that your interpretation also? Bob